OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+33.13%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$520M
AUM Growth
+$520M
(+29%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
4.2%
Top 10 Holdings %
Top 10 Hldgs %
96.83%
Holding
18
New
2
Increased
5
Reduced
5
Closed
–
Top Buys
| 1 |
DERM
Dermira, Inc.
DERM
|
$10.5M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.81M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$4.07M |
| 4 |
AGEN
Agenus
AGEN
|
$3.92M |
| 5 |
Cencora
COR
|
$2.13M |
Top Sells
| 1 |
AXDX
Accelerate Diagnostics
AXDX
|
$2.28M |
| 2 |
Opko Health
OPK
|
$2.11M |
| 3 |
QuidelOrtho
QDEL
|
$2.06M |
| 4 |
CFRX
ContraFect Corporation
CFRX
|
$1.79M |
| 5 |
Biogen
BIIB
|
$445K |
Sector Composition
| 1 | Healthcare | 92.6% |
| 2 | Financials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
QuidelOrtho
QDEL
$1.95B
| $132M | 24.75% |
1,756,988
-27,476
| -2% | -$2.06M |
|
|
AMRN
2
Amarin Corp
AMRN
$311M
| $112M | 21.04% |
5,226,005
+189,785
| +4% | +$4.07M |
|
|
BHVN
3
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $105M | 19.66% |
1,923,290
+143,415
| +8% | +$7.81M |
|
|
AXDX
4
DELISTED
Accelerate Diagnostics
AXDX
| $71.2M | 13.37% |
4,213,152
-134,988
| -3% | -$2.28M |
|
|
DERM
5
DELISTED
Dermira, Inc.
DERM
| $38.3M | 7.2% |
2,528,311
+694,526
| +38% | +$10.5M |
|
6
Soleno Therapeutics
SLNO
$3.6B
| $11.4M | 2.14% |
3,870,627
| – | – |
|
|
AGEN
7
Agenus
AGEN
$133M
| $11.3M | 2.12% |
2,772,103
+963,807
| +53% | +$3.92M |
|
|
MOTS
8
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $8.72M | 1.64% |
3,806,666
| – | – |
|
|
VRML
9
DELISTED
Vermillion, Inc.
VRML
| $7.96M | 1.49% |
9,825,289
| – | – |
|
|
10
Opko Health
OPK
$1.1B
| $6.43M | 1.21% |
4,373,076
-1,437,300
| -25% | -$2.11M |
|
11
Pacific Biosciences
PACB
$393M
| $5.71M | 1.07% |
1,110,666
| – | – |
|
|
ATRS
12
DELISTED
Antares Pharma, Inc.
ATRS
| $3.24M | 0.61% |
688,237
+400,000
| +139% | +$1.88M |
|
|
BIOL
13
DELISTED
Biolase, Inc.
BIOL
| $2.86M | 0.54% |
5,173,250
| – | – |
|
|
14
Cencora
COR
$56.5B
| $2.13M | 0.4% |
+25,000
| New | +$2.13M |
|
|
15
Biogen
BIIB
$19.4B
| $1.44M | 0.27% |
4,868
-1,500
| -24% | -$445K |
|
|
CFRX
16
DELISTED
ContraFect Corporation
CFRX
| $933K | 0.18% |
1,502,766
-2,889,947
| -66% | -$1.79M |
|
17
Deutsche Bank
DB
$67.7B
| $195K | 0.04% |
+25,000
| New | +$195K |
|
18
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|